Companies / Vor Biopharma Inc.
Vor Biopharma Inc.
Nasdaq: VORCIK 1817229BOSTON, MA
Financials
Ownership
59.2M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 4.06% | 2,402,095 |
| 10%+ / strategic | 13.32% | 7,880,103 |
| Institutions | 39.72% | 23,500,648 |
| Public float | 42.90% | 25,379,448 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
RA Capital Management, L.P.Director · 10% owner | 4.06% | 2,402,095 |
Kolchinsky PeterDirector · 10% owner | — | — |
RA Capital Healthcare Fund LPDirector · 10% owner | — | — |
Shah Rajeev M.Director · 10% owner | — | — |
Institutional holders 63
View all →| Holder | Value | % of shares |
|---|---|---|
| $96.43M | 9.14% | |
| $63.85M | 5.86% | |
| $48.17M | 4.42% | |
| $47.31M | 6.11% | |
| $33.27M | 4.30% | |
| $33.04M | 4.27% | |
| $31.22M | 2.96% | |
| $25.42M | 3.29% | |
| $22.89M | 2.96% | |
| $20.57M | 1.95% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $55.28M | +3.0M +644.81% | 3,468,107 5.86% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $46.49M | +2.5M +2773.42% | 2,616,336 4.42% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | — | $20.57M | +1.2M | 1,153,276 1.95% of shares | medium |
| Q1 2026 as of | Great Point Partners, LLC 13F manager | Add | — | $6.78M | +380K +27.73% | 1,750,000 2.96% of shares | medium |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | — | $2.80M | +157K +84.37% | 342,573 0.58% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | — | $2.30M | +129K | 128,839 0.22% of shares | low |
| Q1 2026 as of | Axiom Investors LLC /De 13F manager | New | — | $1.71M | +96K | 95,745 0.16% of shares | low |
| Q1 2026 as of | Rafferty Asset Management, LLC 13F manager | New | — | $901.0K | +51K | 50,505 0.09% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Fmr LLC | Passive13G/A | — |
| Great Point Partners, LLC | Passive13G/A | — |
| Venrock Healthcare Capital Partners III, L.P. | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Qiming Venture Partners VIII-HC, L.P. | Passive13G/A | — |
| Paradigm BioCapital Advisors LP | Passive13G/A | — |
| Verve Capital Limited | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VOR | — | 929033207 |